Company Performance Metrics
- Rohit Gupta: Co-Founder & CEO
- Rishi N. Reddy: Co-Founder & Executive Chairman
ChronicleBio develops an AI-driven techbio platform that aggregates and analyzes multi-omic, clinical, and patient-reported data for complex neuroimmune disorders. The company focuses on conditions such as POTS, ME/CFS, Long COVID, MCAS, Sjögren’s, and Lyme-related illnesses, aiming to clarify disease mechanisms and support targeted therapies.
Its data infrastructure supports clinical research sponsors with tools for trial design, rapid site activation, and diverse patient enrollment. ChronicleBio provides analytics that help identify biomarkers, stratify patient subgroups, and evaluate treatment response. The platform also engages patients through data-sharing programs that connect real-world health information with research needs. Life sciences organizations, academic researchers, and healthcare partners use ChronicleBio’s datasets and insights to shorten research timelines and inform diagnostic and therapeutic development.